Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-25T06:35:49.869Z Has data issue: false hasContentIssue false
  • English
  • Français

Fluoxetine seems to widen the nortriptyline antidepressant-like dose range in mice submitted to the tail suspension test (TST)

Published online by Cambridge University Press:  16 April 2020

IR de Oliveira ,
PR Brito ,
MF Peres ,
R Dardennes ,
MA da Rocha-Junior ,
J Gonidec ,
T Rouyer  and
E de Castro-E-Silva
IR de Oliveira*
Affiliation:
Grupo de Estudos em Neuropsiquiatria e Psicofarmacologia (GENPSI) Laboratório de Neurociências, Departamento de Farmacologia e Fisiologia, ICS, Universidade Federal da Bahia, Vale do Canela, 40140Salvador, Bahia, Brazil
PR Brito
Affiliation:
Grupo de Estudos em Neuropsiquiatria e Psicofarmacologia (GENPSI)
MF Peres
Affiliation:
Grupo de Estudos em Neuropsiquiatria e Psicofarmacologia (GENPSI)
R Dardennes
Affiliation:
Clinique de Maladies Mentales et de l'Encéphale, 100 Rue de la Santé, 75014Paris
MA da Rocha-Junior
Affiliation:
Grupo de Estudos em Neuropsiquiatria e Psicofarmacologia (GENPSI)
J Gonidec
Affiliation:
Laboratoires Delagrange, 1 rue Pierre Brossolete, 91380Chilly-Mazarin, France
T Rouyer
Affiliation:
Laboratoires Delagrange, 1 rue Pierre Brossolete, 91380Chilly-Mazarin, France
E de Castro-E-Silva
Affiliation:
Laboratório de Neurociências, Departamento de Farmacologia e Fisiologia, ICS, Universidade Federal da Bahia, Vale do Canela, 40140Salvador, Bahia, Brazil
*
*Correspondence and reprints: Rua Érico Verissimo, no 340, apt 603, Itaigara, 41850 Salvador, Bahia, Brazi
Get access

Summary

This study was designed to verify whether fluoxetine (FL), a serotonin (5-HT) re-uptake inhibitor, would interfere with nortriptyline (NT), a biphasic U-shaped curvilinear dose-response relationship recently described in our laboratory. We associated 10 mg/kg NT or vehicle to 0, 5, 10, 20 and 40 mg/kg FL, in one group, and 10 mg FL or vehicle to 0, 5, 10, 20 and 40 mg/kg NT, in another group, 30 min before the tail suspension test (TST) in mice. Although we were not able to confirm a synergistic effect between FL and NT, FL-NT association seems to require higher doses of NT to block its own anti-immobility effect at high doses, thus widening NT effective antidepressant-like dose range in mice submitted to TST.

Keywords

fluoxetinenortriptylinemicetail suspension test
Type
Original article
Information
European Psychiatry , Volume 7 , Issue 1 , 1992 , pp. 33 - 37
Copyright
Copyright © Elsevier, Paris 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aranow, RBHudson, JIPope, HGGrady, TALaage, TABell, IRCole, JO (1989) Elevated antidepressant plasma levels after addition of fluoxetine Am J Psychiatry 146, 911–913Google ScholarPubMed
Asberg, MCronholm, BSjoqvist, FTuck, D (1971) Relationship between plasma levels and therapeutic effect of nortriptyline Br Med J 3, 331–334CrossRefGoogle ScholarPubMed
Baron, BMOgden, QMSiegel, BWStegeman, JUrsillo, RCDedley, MW (1988) Rapid down-regulation of betaadrenoceptors by co-administation of desipramine and fluoxetine Eur J Pharmacol 154, 125–134CrossRefGoogle Scholar
Beasley, CMBosomworth, JCWernicke, JF(1990) Fluoxetine: Relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression Psychopharmacol Bull 26, 18–24Google ScholarPubMed
Bell, IRCole, JO (1988) Fluoxetine induced elevation of desipramine level and exacerbation of geriatric nonpsychotic depression (letter) J Clin Psychopharmacol 8, 447–448CrossRefGoogle Scholar
Ciraulo, ADShader, RI (1990) Fluoxetine drug-drug interactions: I. Antidepressants and antipsychotics J Clin Psychopharmacol 10, 48–50CrossRefGoogle ScholarPubMed
De Oliveira, IRDiquet, BVan der Meersch, VGonidec, JPrado-Lima, PAS (1989a) Higher blood and brain concentrations of imipramine and desipramine seem not to impair anti-immobility effect in mice Psychiatr & Psychobiol 4, 369–373Google Scholar
De Oliveira, IRPrado-Lima, PASSamuel-Lajeunesse, B (1989b) Monitoring of tricyclic antidepressant plasma levels and clinical response: A review of the literature Psychiatr & Psychobiol 4, 43–60, 81-90Google Scholar
De Oliveira, IRDiquet, BVan der Meersch, VDardennes, RGonidec, JPrado-Lima, PAS (1990) Self inhibiting action of nortriptyline's anti-immobility effect at high plasma and brain levels in mice Psychopharmacol 102, 553–556CrossRefGoogle Scholar
Dunnett, CW (1964) New tables for multiple comparisons with a control Biometrics 20, 483–489CrossRefGoogle Scholar
Goodnick, PJ (1989) Influence of fluoxetine on plasma levels of desipramine (letter) Am J Psychiatry 146, 552Google Scholar
Hall, HOgren, SO (1981) Effects of antidepressant drugs on different receptors in the brain Eur J Pharmacol 70, 393–407CrossRefGoogle Scholar
Kragh-Sorensen, PHansen, CBaastrup, PCHvidberg, EF (1976) Self-inhibiting action of nortriptyline's antidepressive effect at high plasma levels Psychopharmacol, 45 305–312CrossRefGoogle Scholar
Martin, PSoubrié, PPuech, AJ (1990) Reversal of helpless behavior by serotonin uptake blockers in rats Psychopharmacol 101, 403–407CrossRefGoogle ScholarPubMed
Nelson, JCMazure, CMBowers, MBJatlow, PI (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression Arch Gen Psychiatry 48, 303–307CrossRefGoogle ScholarPubMed
Stéru, LChermat, RThierry, B (1985) The tail suspension test: A new method lor screening antidepressants in mice Psychopharmacol 85, 367–370CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.